Benjamin Schwalm
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Molecular characterization of mismatch repair deficient tumors in young Jordanian patients.
Journal: Discover oncology
Published: March 03, 2026
CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models.
Journal: The Journal of clinical investigation
Published: November 25, 2025
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.
Journal: Cancer research
Published: November 19, 2025
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions.
Journal: Nature cancer
Published: August 24, 2024
Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
Journal: EMBO molecular medicine
Published: June 21, 2023
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma.
Journal: Neuro-oncology advances
Published: April 27, 2022
Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir.
Journal: International journal of molecular sciences
Published: February 24, 2022
The molecular landscape of ETMR at diagnosis and relapse.
Journal: Nature
Published: December 21, 2018
A biobank of patient-derived pediatric brain tumor models.
Journal: Nature medicine
Published: July 12, 2017
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
Journal: Neuro-oncology
Published: May 09, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026